Duke-NUS Medical School Aug 14 2025 65LAB has awarded US$1.5 million (approx. S$1.9 million) to Professor Enrico Petretto to advance a breakthrough drug discovery platform developed at Duke-NUS Medical School. The project aims to deliver first-in-class antifibrotic therapies for lung and kidney diseases-conditions that currently have no effective treatment. The platform, known as Systems Genetics, integrates computational biology with Artificial Intelligence (AI) algorithms and is being